Ecuador vs Russian Federation: Treatment success rate for patients treated for MDR-TB
Ecuador
65.0%
in 2022
Russian Federation
65.0%
in 2022
Ecuador rank
113th
Russian Federation rank
113th
Treatment success rate for patients treated for MDR-TB over time
- Ecuador
- Russian Federation
How they compare
Ecuador currently reports 65.0% against 65.0% in Russian Federation, a difference of 0.0%.
The two have swapped places 5 times across 11 shared years of data; in 2008 it was Ecuador ahead.
Ecuador ranks 113th and Russian Federation ranks 113th of 163 countries.
Across the 3 decades both report, Ecuador averaged higher in 2 and Russian Federation in 1.
Head to head by decade
| Decade | Ecuador | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 64.0% | 51.0% | 13.0% | Ecuador |
| 2010s | 48.7% | 46.7% | 2.0% | Ecuador |
| 2020s | 53.0% | 56.7% | 3.7% | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Ecuador or Russian Federation?
- Ecuador, at 65.0% against 65.0% in Russian Federation as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Ecuador and Russian Federation?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Russian Federation?
- 11 years are reported by both, from 2008 to 2022.
- How do Ecuador and Russian Federation rank globally for treatment success rate for patients treated for mdr-tb?
- Ecuador ranks 113th and Russian Federation ranks 113th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.